Relation of body fluid status to B-type natriuretic peptide levels in patients with chronic heart failure during long-term follow-up

Clinical Cardiology

Volumn 29, Issue 10, 2006, Pages 457-461

  Kataoka, Hajime ^a,b  

^a Nishida Hospital   (Japan)

^b Nishida Hospital   (Japan)

Author keywords

B type natriuretic peptide; Heart failure; Physical sign; Pleural effusion; Ultrasonography

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; FEMALE; FLUID RETENTION; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HEART FAILURE; HUMAN; MALE; PATIENT MONITORING; RELIABILITY;

EID: 33749635823     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960291008     Document Type: Article

References (21)

1. Bhalla V, Willis S, Maisel AS: B-type natriuretic peptide: The level and the drag-partners in the diagnosis and management of congestive heart failure. Congest Heart Fail 2004;10(1 suppl 1):3-27
2. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical maker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832
3. Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A: A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study. J Cardiac Fail 2001;7:21-29
4. Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, Redfield MM, Burnett JC: The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Cardiac Fail 2002;8:149-154
5. Tang WHW, Francis GS: The difficult task of evaluating how to monitor patients with heart failure. J Cardiac Fail 2005;11:422-424
6. Wu AHB, Smith A: Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure. Eur J Heart Fail 2004;6:355-358
7. Bruins S, Fokkema MR, Römer JWP, DeJongste MJL, van der Dijs FPL, van den Ouweland JMW, Muskiet FAJ: High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-2058
8. Lewin J, Ledwidge M, O'Loughlin C, McNally C, McDonald K: Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail 2005;7:953-957
9. Kataoka H, Takada S: The role of thoracic ultrasonography for evaluation of patients with decompensated chronic heart failure. J Am Coll Cardiol 2000;35:1638-1646
10. Jones AE, Kline JA: Pleural effusions in the critically ill: The evolving role of bedside ultrasound. Crit Care Med 2005;33:1874-1875
11. Ghali JK, Kadakia S, Cooper R, Ferlinz J: Precipitating factors leading to decompensation of heart failure: Traits among urban blacks. Arch Intern Med 1988;148:2013-2016
12. Abdulla J, Køber L, Torp-Pedersen C: Methods of assessing the functional status of patients with left ventricular systolic dysfunction in interventional studies. Cardiovasc Drugs Ther 2004;18:219-224
13. Silver MA, Rosendorff C, Berkowitz R, Peacock WF IV: Current and emerging issues with B-type natriuretic peptide. Congest Heart Fail 2005;11:212-214
14. Tang WHW, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F, Francis GS: Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 2003;108:2964-2966
15. McGeoch G, Lainchbury J, Town GI, Toop L, Espiner E, Richards AM: Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Fail 2002;4:479-483
16. Braunschweig F, Linde C, Eriksson MJ, Hofman-Bang C, Rydén L: Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 2002;23:59-69
17. Androne AS, Hryniewicz K, Hudaihed A, Manciri D, Lamanca J, Katz SD: Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 2004;93:1254-1259
18. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H: B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-748
19. Rademaker MT, Charles CJ, Kosoblou T, Protter AA, Espiner EA, Nicholls MG, Richards AM: Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure. Am J Physiol 1997;273: H2372-2379
20. Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, Vasan RS: Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 2003;108:13-16
21. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: Impact of age and gender. J Am Coll Cardiol 2002;40:976-982